久久99国产这里只有精品/欧美黄片大全/男生晚上睡不着想看点害羞的/小可爱免费直播下载 - 久色网

首頁 ? JHOS-3 NTCC?人卵巢漿液腺癌細胞系human ovarian serous adenocarcinoma cell line-BioVector NTCC Inc.

JHOS-3 NTCC?人卵巢漿液腺癌細胞系human ovarian serous adenocarcinoma cell line-BioVector NTCC Inc.

  • 價  格:¥49850
  • 貨  號:NTCC?-JHOS-3
  • 產  地:北京
點擊詢問我要采購
 竭誠為您服務!
BioVector NTCC典型培養物保藏中心
聯系人:Dr.Xu, Biovector NTCC Inc.

電話:400-800-2947 工作QQ:1843439339 (微信同號)

郵件:Biovector@163.com

手機:18901268599

地址:北京

已注冊
 

JHOS-3 NTCC?人卵巢漿液腺癌細胞系

BioVector NTCC質粒載體菌株細胞蛋白抗體基因保藏中心


JHOS-3 is a human ovarian serous adenocarcinoma cell line. It's particularly valuable for studying:

  • Ovarian cancer biology: Understanding the molecular mechanisms underlying ovarian cancer development and progression.

  • Drug resistance: Investigating how ovarian cancer cells develop resistance to chemotherapy drugs.

  • Drug discovery and development: Screening potential anticancer drugs and evaluating their efficacy against ovarian cancer cells.

  • Tumor microenvironment: Studying the interactions between tumor cells and the surrounding host tissue.

Key characteristics of JHOS-3 cells:

  • Drug resistance: Relatively resistant to many chemotherapeutic agents, making it a useful model for studying drug resistance mechanisms.

  • Tumorigenic: Can form tumors when injected into animals, allowing researchers to study tumor growth and metastasis.

  • Well-characterized: Its genetic and phenotypic properties are well-documented.

By studying JHOS-3 cells, researchers can gain valuable insights into the biology of ovarian cancer and develop more effective treatments for patients with this disease.

Image

Establishment and characterization of a cell line (HCH-1) originating from  a human clear cell carcinoma of the ovary | Journal of Ovarian Research |  Full Text

生產廠家Supplier:

BioVector NTCC質粒載體菌株細胞蛋白抗體基因保藏中心

E-mail:BioVector@163.com


http://www.biovector.net


您正在向 biovector.net  發送關于產品 JHOS-3 NTCC?人卵巢漿液腺癌細胞系human ovarian serous adenocarcinoma cell line-BioVector NTCC Inc. 的詢問

點擊“立即發送”后,我們將在1個工作日內與您取得聯系。